COMPOUND W PLUS LIQ 30% 30 %
SALICYLIC ACID : 30 % · DIN 01948156 · WHITEHALL-ROBINS INC.
Health Canada status: CANCELLED POST MARKET
What is COMPOUND W PLUS LIQ 30%?
COMPOUND W PLUS LIQ 30% 30 % contains SALICYLIC ACID : 30 %. It is listed in the Health Canada Drug Product Database under DIN 01948156, held by WHITEHALL-ROBINS INC., supplied as LIQUID for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 07-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01948156 |
|---|---|
| Brand name | COMPOUND W PLUS LIQ 30% |
| Generic / active ingredient | SALICYLIC ACID : 30 % |
| Manufacturer | WHITEHALL-ROBINS INC. |
| Strength | 30 % |
| Dosage form | LIQUID |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D11AF WART AND ANTI-CORN PREPARATIONS |
| AHFS class | 84:28.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 07-Aug-1997 |
| Original market date | 1992-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D11AF WART AND ANTI-CORN PREPARATIONS. 1 of 33 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CANTHARONE PLUS | 1 % | LIQUID | DORMER LABORATORIES INC. | MARKETED | DIN 00772011 |
| BAND-AID BRAND MEDICATED CORN REMOVER | 40 % | PAD | JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02241129 |
| BICHLORACETIC ACID 100% | 100 % | LIQUID | GLENWOOD INC. | CANCELLED POST MARKET | DIN 00800708 |
| CANTHACUR-PS | 1 % | LIQUID | PALADIN PHARMA INC. | CANCELLED POST MARKET | DIN 00589500 |
| CARNATION CALLOUS CAPS | 40 % | PLASTER | CUXSON GERRARD & CO LTD. | CANCELLED POST MARKET | DIN 00307904 |
| COMPOUND W GEL 17% | 17 % | GEL | WHITEHALL-ROBINS INC. | CANCELLED POST MARKET | DIN 01929429 |
| COMPOUND W LIQUID 20% | 20 % | LIQUID | WHITEHALL-ROBINS INC. | CANCELLED POST MARKET | DIN 01977725 |
| CORN SALVE ONT 15% | 15 % | OINTMENT | SCHERING-PLOUGH HEALTHCARE PRODUCTS CANADA, A DIVISION OF SCHERING CANADA INC. | CANCELLED POST MARKET | DIN 01911384 |
| CUPLEX GEL | 4 % | GEL | TRANS CANADERM INC. | CANCELLED POST MARKET | DIN 00820377 |
| DR. SCHOLL'S 2-DROP CORN REMEDY | 12.64 % | LIQUID | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 01981463 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.